UBROGEPANT vs UMBRALISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
UBROGEPANT vs UMBRALISIB: Safety Overview
| Metric | UBROGEPANT | UMBRALISIB |
|---|---|---|
| Total FAERS Reports | 2,531 | 293 |
| Deaths Reported | 49 | 30 |
| Death Rate | 1.9% | 10.2% |
| Hospitalizations | 145 | 97 |
| Average Patient Age | 49.2 yrs | 69.0 yrs |
| % Female Patients | 83.6% | 43.8% |
| FDA Approval Date | Dec 23, 2019 | Feb 5, 2021 |
| Manufacturer | Allergan, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Discontinued |